These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9269630)

  • 1. Cyclosporin or tacrolimus: which agent to choose?
    Danovitch GM
    Nephrol Dial Transplant; 1997 Aug; 12(8):1566-8. PubMed ID: 9269630
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine.
    Kobashigawa JA
    Transplant Proc; 1998 Jun; 30(4):1095-7. PubMed ID: 9636445
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising immunosuppression.
    Schafer DF; Sorrell MF
    Lancet; 2002 Oct; 360(9340):1114-5. PubMed ID: 12387953
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver/kidney transplantation: A systematic review and meta-analysis.
    Gong X; Li J; Yan J; Dai R; Liu L; Chen P; Chen X
    J Clin Pharm Ther; 2021 Jun; 46(3):744-753. PubMed ID: 33386628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy.
    Pretagostini R; Rossi M; Colonnello M; Novelli G; Berloco P; Venettoni S; Cortesini R
    Transplant Proc; 2001; 33(1-2):1025-6. PubMed ID: 11267174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninfectious uveitis: a scarcity of randomized clinical trials.
    Okada AA
    Arch Ophthalmol; 2005 May; 123(5):682-3. PubMed ID: 15883289
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Emovon OE; Browne BJ
    Lancet; 2002 Sep; 360(9335):799; author reply 800-1. PubMed ID: 12241844
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing proteinuria control with cyclosporin and tacrolimus.
    Budde K; Fritsche L; Neumayer HH
    Lancet; 1997 Feb; 349(9048):330. PubMed ID: 9024386
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of pancreas transplants to FK 506 from CsA.
    Tesi RJ; Bryer-Ash M; Jaspan J; Byer-Ashe M [corrected to Bryer-Ash M]
    Transplant Proc; 1995 Dec; 27(6):3032-3. PubMed ID: 8539828
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Vella JP; Sayegh MH
    Postgrad Med J; 1997 Jul; 73(861):386-90. PubMed ID: 9338020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of gingival overgrowth following change from cyclosporin to tacrolimus therapy in a renal transplant patient.
    Kennedy DS; Linden GJ
    J Ir Dent Assoc; 2000; 46(1):3-4. PubMed ID: 11323935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing proteinuria control with cyclosporin and tacrolimus.
    Krämer BK; Schweda F
    Lancet; 1997 Mar; 349(9056):953-4. PubMed ID: 9093272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.